KozaYSenocakH. The inconclusive results of the studies on glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease: an area of darkness. Angiology. 2015;66(1):86–87.
2.
VerdoiaMCassettiESchafferA. Relationship between glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease. Angiology. 2015;66(1):79–85.
3.
De LucaGSantagostinoMSeccoGG. Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study. J Thromb Thrombolysis. 2010;30(4):426–433.
4.
De LucaGVenegoniLIorioS. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets. 2010;21(7):508–514.
5.
De LucaGSantagostinoMSeccoGG. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206(1):292–297.
WeissEJBrayPFTaybackM. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334(17):1090–1094.
8.
ArdissinoDMannucciPMMerliniPA. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 1999;94(1):46–51.
9.
Garcia-RibesMGonzalez-LamuñoDHernandez-EstefaniaR. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost. 1998;79(6):1126–1129.
10.
Abboud AbboudNGhazouaniLBen-Hadj-KhalifaS. Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease. J Thromb Thrombolysis. 2010;29(4):409–415.
11.
BöttigerCKastratiAKochW. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost. 2000;83(4):559–562.
12.
LagercrantzJBergmanMLundmanP. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction. Blood Coagul Fibrinolysis. 2003;14(8):749–753.
13.
AlecsikNJunejaHFolsomAR. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 2000;102(16):1901–1512.
14.
Di CastelnuovoAde GaetanoGDonatiMBIacovielloL. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost. 2001;85(4):626–633.
15.
YeZLiuEHHigginsJP. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367(9511):651–658.
16.
BonelloLTantryUSMarcucciR. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56(12):919–933.
17.
VerdoiaMPergoliniPCamaroC. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. Blood Coagul Fibrinolysis. 2013;24(4):411–418.
